Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale "PFO-HUG"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- 18 years old patients
- signed informed consent
- all consecutive patients undergoing a successful percutaneous closure of a PFO secondary to a cryptogenic stroke

Exclusion Criteria

- all patients with an alternative aetiology of the initial stroke
- all patients in whom the percutaneous closure of the PFO is contraindicated
- all patients with a known allergy to aspirin and or clopidogrel